Alternative
Kratom
search
Kratom
, Mitragyna Speciosa
See Also
Opioid Abuse
Background
Herbal stimulant at low dose and with
Opioid
effects at higher dose
Currently legal in U.S. to purchase at gas stations and smoke shops
U.S. sales are >1 Billion/year (as of 2025)
Marketed in capsule, liquid and powder form
Not yet categorized as controlled substance
FDA has had concerns regarding serious adverse effects including death
Mechanism
Extracted from leaves of tropical tree (Mitragyna Speciosa) within coffee family, grown in Southeast Asia
Leaves have traditionally been chewed or brewed as a tea
Stimulant effects at low dose (2-3 grams, as traditionally used, leaf form)
Opioid
effects at high dose (5-8 grams, concentrated, marketed forms, capsules)
Also acts at
Serotonin
and
Dopamine
receptors
Active ingredients and active metabolites
Mitragynine (most abundant in leaves, 0.25 MME or
Morphine Equivalent
s)
7-Hydroxymitragynine (10-13 MME or
Morphine Equivalent
s)
Intoxicated presentations are often mixes of Kratom with other substances
Kratom laced with other intoxicants
Coingestion of other intoxicants
Pharmacokinetics
Onset: 10-15 min
Duration: 4-6 hours
Adverse Effects
Stimulant effects
Palpitation
s
Sinus Tachycardia
Hypertension
Tremor
Opioid
Effects
Drowsiness
Nausea
Confusion
Constipation
Opioid Withdrawal
(onset 12-24 hours after last dose, duration 3-7 days)
Anxiety
Insomnia
Agitation
Flushing
or sweating
High Dose, Toxicity or
Overdose
Hepatotoxicity (cholestatic hepatitis)
Seizure
s
Respiratory Depression (rare without coingestion)
Cardiac Arrest
(rare without coingestion)
Chronic Use
Weight loss or
Anorexia
Dependence
Hyperpigmentation
Constipation
Psychiatric effects
Management
Symptomatic management
Kratom Withdrawal
Treat in similar fashion to
Opioid Withdrawal
Drug Interactions
Inhibits many
Cytochrome P450
metabolism pathways (increases other drug levels)
CYP1A2 Inhibitor
CYP2D6 Inhibitor
CYP3A4
Inhibitor
Resources
Kratom (FDA)
https://www.fda.gov/news-events/public-health-focus/fda-and-kratom
Kratom (DEA)
https://www.dea.gov/sites/default/files/2020-06/Kratom-2020_0.pdf
References
(2016) Presc Lett 23(11)
(2025) Presc Insights, Issue 3/2025
Morrison and Nordt (2026) Kratom, EM:Rap, 1/26/2026
Type your search phrase here